α5 Nicotinic Receptor Polymorphism affects cigarette smoke-induced inflammation and COPD development

Area of Science:

• Respiratory Medicine
• Genetics
• Immunology

Background:

• Chronic Obstructive Pulmonary Disease (COPD) is a leading global cause of death, with cigarette smoke being the primary risk factor.
• Genetic susceptibility plays a crucial role, as only a subset of smokers develop COPD.
• The alpha-5 nicotinic acetylcholine receptor polymorphism (α5SNP; rs16969968) is implicated in immune responses to cigarette smoke and is found in most COPD patients.

Purpose of the Study:

• To investigate the influence of α5SNP on cigarette smoke-induced inflammation and COPD pathogenesis.
• To evaluate the role of α5SNP in both experimental models and human COPD cohorts.

Main Methods:

• A murine knock-in model with varying α5SNP alleles (WT, HE, HO) was exposed to cigarette smoke for 1-3 months.
• Evaluated lung function, histopathology, immune cell profiling, and cytokine expression in mice.
• Assessed α5SNP prevalence and cytokine concentrations in a human COPD cohort.

Main Results:

• Cigarette smoke exposure worsened lung function across genotypes, with heterozygous (HE) mice showing the most severe airflow limitation, inflammation, and airway remodeling.
• The observed phenotype in HE mice was associated with increased γδ T cell activation and TNF-α, linked to altered macrophage nAChR signaling.
• In humans, α5SNP was highly prevalent in COPD patients and correlated with elevated systemic inflammation.

Conclusions:

• The α5SNP genetic variant enhances susceptibility to cigarette smoke-induced lung injury.
• α5SNP is a significant genetic marker for COPD susceptibility and is present in the majority of affected patients.
• Identifying α5SNP in smokers warrants precise follow-up due to increased COPD risk.